Today "Chennai (Madras), India " News and Relevant News on "Chennai (Madras), India " as Parts

Keyword: Chennai (Madras), India

Century Park Law Group - centuryparklawgroup.com News Center

Phrase Selected: Chennai (Madras) India

Keyword Selected: Chennai

2024 Maruti Swift Bookings Commence, Launch On 9th May

2024 Maruti Swift bookings open, officially teased for the first time in India The fourth generation Maruti Swift has been teased officially for the...

The post 2024 Maruti Swift Bookings Commence, Launch On 9th May appeared first on MotorBeam.


Mahindra XUV 3XO Launched, Priced From Rs. 7.49 Lakhs

Mahindra XUV 3XO price revealed, available in 9 variants and 8 colour options Mahindra XUV 3XO launched with a starting price of Rs. 7.49...

The post Mahindra XUV 3XO Launched, Priced From Rs. 7.49 Lakhs appeared first on MotorBeam.


Affordable Strong Hybrid Tech Under Development For Indian Market

Maruti Suzuki to launch affordable hybrid cars in the near future Maruti Suzuki Chairman R.C. Bhargava disclosed the ongoing efforts by Suzuki Japan to...

The post Affordable Strong Hybrid Tech Under Development For Indian Market appeared first on MotorBeam.


Bajaj Pulsar NS400 Spied Undisguised Ahead Of Launch

Bajaj Pulsar NS400 spied, the biggest capacity Pulsar yet Bajaj Auto is gearing up for the launch of its much anticipated Bajaj Pulsar NS400...

The post Bajaj Pulsar NS400 Spied Undisguised Ahead Of Launch appeared first on MotorBeam.


2024 Force Gurkha 3-Door & 5-Door Review

The post 2024 Force Gurkha 3-Door & 5-Door Review appeared first on MotorBeam.


Kia Carens DCT Travelogue a Comfortable Weekend Trip

Travelling has been a passion in my family. We do quite a few trips but road trips are something that is becoming a ritual...

The post Kia Carens DCT Travelogue – Comfortable Weekend Trip appeared first on MotorBeam.


Maruti Suzuki Fronx Long Term Review a Final Report

Maruti Suzuki Fronx Long Term Review Car Tested: Maruti Suzuki FronxKms Done: 5361 kmsTest Started at: 5071 kmsTest Concluded at: 10,432 kmsMileage: 13.2 km/l,...

The post Maruti Suzuki Fronx Long Term Review – Final Report appeared first on MotorBeam.


Ford Ranger Spotted Undisguised In India, Launch Soon?

Ford Ranger spied undisguised in India, launch expected via CBU route Speculations regarding the potential return of Ford to the Indian market have been...

The post Ford Ranger Spotted Undisguised In India, Launch Soon? appeared first on MotorBeam.


Skoda Compact SUV Spotted, Revealing New Details

Skoda compact SUV spotted in near production avatar, fully camouflaged Skoda compact SUV spotted testing yet again but this time around more details have...

The post Skoda Compact SUV Spotted, Revealing New Details appeared first on MotorBeam.


Lamborghini Urus SE Is Most Powerful Version Of This SUV

Lamborghini just showed off a new version of their Urus SUV called the Urus SE which is a plug-in hybrid. This is the second...

The post Lamborghini Urus SE Is Most Powerful Version Of This SUV appeared first on MotorBeam.


BMW i5 M60 xDrive Launched In India, Priced At Rs. 1.19 Crores

BMW i5 imported to India directly via CBU route, available in range topping trim BMW i5 M60 xDrive launched in India with a price...

The post BMW i5 M60 xDrive Launched In India, Priced At Rs. 1.19 Crores appeared first on MotorBeam.


Jeep Wrangler Facelift Launched In India, Priced From Rs. 67.65 Lakhs

Jeep Wrangler facelift gets visual changes and updated features on offer Jeep Wrangler facelift launched in India with prices starting from Rs. 67.65 lakhs...

The post Jeep Wrangler Facelift Launched In India, Priced From Rs. 67.65 Lakhs appeared first on MotorBeam.


Mercedes G-Class Electric Revealed, India Bound

Mercedes G-Class goes electric, looks very similar to the ICE powered variants Mercedes-Benz has unveiled the highly anticipated G-Class electric SUV ahead of its...

The post Mercedes G-Class Electric Revealed, India Bound appeared first on MotorBeam.


Ultraviolette F77 Mach 2 Launched, Priced From Rs. 2.99 Lakhs

Ultraviolette F77 Mach 2 gets more features, better range & lower price tag Ultraviolette, the Bengaluru-based electric vehicle startup, has unveiled its latest offering,...

The post Ultraviolette F77 Mach 2 Launched, Priced From Rs. 2.99 Lakhs appeared first on MotorBeam.


Honda Amaze Receives 2 Stars In Global NCAP Crash Test

Honda Amaze crash test score is 2 stars for adult and 0 star for child occupant safety In a recent round of crash test...

The post Honda Amaze Receives 2 Stars In Global NCAP Crash Test appeared first on MotorBeam.


Insulin pill may delay type 1 diabetes in some

It’s often said that timing is everything. New research suggests this may be true when giving an insulin pill to try to prevent or delay type 1 diabetes. Researchers tested the effect of insulin pills on 560 children and adults whose relatives had type 1 diabetes. For most of them, the drug had no effect on whether or not they developed type 1 diabetes, or how quickly they developed it. But for those at the highest risk of developing type 1 diabetes sooner rather than later, insulin pill therapy delayed the time it took to develop the full-blown disease by about two-and-a-half years, the researchers said.

OneTouch Via enabled diabetes patients to report improved insulin dose compliance

People with type 1 and type 2 diabetes who used the new OneTouch Via™ mealtime, on-demand insulin delivery system reported they missed fewer doses and felt less stress about dosing compared to multiple daily injections, according to research presented by Calibra Medical, Inc., one of the Johnson & Johnson Diabetes Care Companies, at the annual American Diabetes Association (ADA) conference. Results of the Market Acceptance Evaluation (MAE) study also demonstrated that physicians were more likely to recommend the innovative insulin delivery device to patients who are not at A1C goals or who are new to rapid-acting insulin (RAI) therapy. The new OneTouch Via™ is a wearable, on-demand insulin delivery system in development that allows patients to discreetly deliver rapid-acting, or bolus, insulin at mealtimes by simply pressing two buttons on the device, accessible even through clothing. The thin, water-resistant patch can be worn continuously for up to three days, providing injection-free delivery of insulin when needed. “People with diabetes can often feel embarrassment or discomfort when they need to inject insulin at mealtimes or when snacking. In a social situation, they may choose to miss a dose so they don’t have to take themselves out of the moment, but avoiding needed insulin doses may lead to serious health complications over time,” said Dr. Brian Levy, Chief Medical Officer, Lifescan, Inc. “Because patients in the study were empowered to dose discreetly with the OneTouch Via™, they felt encouraged to dose more often - and ultimately, they reported missing fewer doses and better adherence to their treatment regimen.”

Rice study details stress-diabetes link

A Rice University study has found a link between emotional stress and diabetes, with roots in the brain’s ability to control anxiety. That control lies with the brain’s executive functions, processes that handle attention, inhibition, working memory and cognitive flexibility and are also involved in reasoning, problem-solving and planning. The study published in Psychoneuroendocrinology establishes a metabolic chain reaction that starts with low inhibition, aka attention control, which leaves a person vulnerable to tempting or distracting information, objects, thoughts or activities. Previous studies have shown that such vulnerability can lead to more frequent anxiety, and anxiety is known to activate a metabolic pathway responsible for the production of pro-inflammatory cytokines, signaling proteins that include interleukin-6 (IL-6).

Liraglutide may help nondiabetic overweight and obese adults lose weight and lower risks

For people with prediabetes who are overweight or obese, adding 3.0 mg of liraglutide for three years to a diet and exercise plan may lead to major health improvements, new industry-sponsored research suggests. The results will be presented Monday, April 4, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston. “Treatment with subcutaneous liraglutide 3.0 mg for three years, combined with a reduced-calorie diet and increased physical activity, can help people to not only lose weight, but also reduce the risk of Type 2 diabetes and improve cardiometabolic risk factors, which may ultimately reduce the risk of cardiovascular disease - the number one cause of death globally,” said lead study author Ken Fujioka, MD, director of nutrition and metabolic research, and director for weight management at Scripps Research Institute in La Jolla, California. “Type 2 diabetes is a major cause of death in the US. Both obesity, a chronic disease with serious health consequences, and prediabetes, typically defined as blood glucose concentrations that are higher than normal but lower than diabetes thresholds, increase the risk of developing Type 2 diabetes,” Fujioka said. “For people with overweight or obesity and prediabetes, losing between 5 and 10 percent of their body weight can reduce their risk of Type 2 diabetes and other obesity-related health consequences.”

Seaweed capsules may lead to an injection-free life for diabetic patients

Diabetes is one of the leading causes of death. Patients with type 1 diabetes have their insulin secreting cells destroyed by the immune system and require daily insulin injections. Pancreatic islet transplantation is an effective treatment that can dramatically reduce daily doses or even eliminate dependence on external insulin. Insulin producing cells are injected into a recipient liver. After an adaptation period they start to produce sufficient hormone needed by diabetic patients. However, while the transplantation procedure itself has been greatly improved in recent years, collection, preservation, and transportation of these cells are still very challenging. Research published in Advanced Healthcare Materials by the scientists from the Okinawa Institute of Technology and Science Graduate University (OIST) in collaboration with the University of Washington and Wuhan University of Technology offers a solution for some of these problems. Production and secretion of insulin occur in the pancreas - an endocrine gland in the digestive system. Cells secreting insulin are clustered in pancreatic islets. Despite their crucial role in organismal wellbeing these islets comprise only a few percent of the pancreatic tissue. The islet transplantation does not require major surgical intervention and is often done under local anaesthesia. It is also cheaper and might be safer than transplantation of the entire pancreas. Unfortunately, so far, only human islets can be transplanted and their supply is but a trickle.

Plant hormone may play a vital role in blood sugar control and diabetes management

A treatment for managing blood sugar levels might be as close as the local health food store, suggests a new research report published in the December 2015 issue of The FASEB Journal. Specifically scientists from Italy have found that when the plant and mammal hormone, abscisic acid, is taken in low doses, glycemia in both rats and humans is reduced. This suggests that by reducing the chronic stimulation by hyperglycemia of β-cells to the release of insulin, chronic low-dose abscisic acid administration may prolong the survival and function of these cells. “These results warrant further studies, aimed at developing new pharmacologic approaches to diabetes prevention and/or treatment,” said Mirko Magnone, Ph.D., a researcher involved in the work from the Department of Experimental Medicine at the University of Genova School of Medicine in Genova, Italy. Scientists examined the presence of abscisic acid in plants and fruits and explored the effect of abscisic acid-rich vegetable extracts on glycemia in rats and in humans. Synthetic abscisic acid, an abscisic acid-rich fruit extract, or placebo were administered to rats together with an oral glucose load. Then glycemia and insulinemia profiles were compared. Then a fruit extract or placebo was administered to human volunteers together with an oral glucose load or with a standard breakfast and lunch. Glucose and insulin levels were then compared with and without abscisic acid. Glycemia and insulinemia profiles from the human oral glucose tolerance tests were also compared with those from 12 normal subjects undergoing a standard oral glucose tolerance test.

Genetic variant shown to influence women’s body shape and diabetes risk

A genetic variant near the KLF14 gene regulates hundreds of genes that govern how and where women’s bodies store fat, which affects their risk of developing Type 2 diabetes, according to research presented at the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore. Specifically, different alleles, or versions, of the variant cause fat-storing cells to function differently. “At the whole-body level, these differences between alleles are not associated with changes to overall weight or body mass index, but they do affect women’s hip circumference,” explained Kerrin Small, PhD, Head of the Genomics of Regulatory Variation Research Group at King’s College London and lead author on the study. “Previous studies have shown that on average, women who carry fat in their hips - those with a ‘pear-shaped’ body type - are significantly less likely to develop diabetes than those with smaller hips. Looking at the variant we studied, large-scale genome-wide association studies show that women with one allele tend to have larger hips than women with the other one, which would have a protective effect against diabetes,” she said.

Endoplasmic reticulum stress plays significant role in type 2 diabetes

A new research report published in the October 2015 issue of the Journal of Leukocyte Biology, suggests that the endoplasmic reticulum plays a more important role in type 2 diabetes and its complications than previously believed. Specifically, when this cell compartment undergoes disruptions (stress) patients experienced poor glycemic control, dyslipidemia, insulin resistance and inflammatory and oxidative stress. Targeting ER stress might be an effective treatment strategy for type 2 diabetes. “In a way, we observed a ‘disharmonious stress signaling alliance’ in diabetes,” said Muthuswamy Balasubramanyam, a senior researcher and disease-biologist involved in the work from the Madras Diabetes Research Foundation in Chennai, India. “The future of potential practical applications of our research is that this would lead to the development of ‘chemical chaperones’ as a new generation class of anti-diabetic agents that should improve ER folding capacity, help to stabilize protein conformation and ameliorate ER stress,” he added. To make their discovery, scientists identified several endoplasmic reticulum stress markers increased in cells from patients with type 2 diabetes as compared to healthy control subjects.

Identifying the ‘dimmer switch’ of diabetes

Patrick MacDonald has dedicated much of his life to diabetes research. It’s a job he knows is far too large and complex for any one person, but with his latest publication, he knows his work is playing a part. MacDonald, a Canada Research Chair in Islet Biology, associate professor in the University of Alberta’s Faculty of Medicine & Dentistry and member of the Alberta Diabetes Institute, is the senior author of a landmark study in the Journal of Clinical Investigation. The researchers examined pancreatic islet cells from 99 human organ donors and identified a new molecular pathway that manages the amount of insulin produced by the pancreatic cells - essentially a ‘dimmer’ switch that adjusts how much or how little insulin is secreted when blood sugar increases. According to MacDonald, the dimmer appears to be lost in Type 2 diabetes but can be restored and ‘turned back on’ - reviving proper control of insulin secretion from islet cells of people with Type 2 diabetes.

Pot Smoking May Increase Prediabetes Risk

Marijuana use in early adulthood was associated with an increased risk for prediabetes, but not diabetes, by middle adulthood in an adjusted analysis of data from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Current marijuana use was associated with a 65% increase in prediabetes risk and very frequent use (≥100 uses) was associated with a 49% increase in risk, researcher Michael P. Bancks, MPH, of the University of Minnesota, in Minneapolis, and colleagues wrote in the journal Diabetologia. Previous Studies Suggest Metabolic Benefit The findings appear to contradict those of many previous studies, which suggest an overall beneficial effect on metabolic risk associated with marijuana use.

State Of Montana Arrest Reports Free Online Download

The actuality is that you are living in a large globe. And it is rather difficult for you to get to know all the folks you are working and doing the job with. Just the same, it is pretty critical to test your finest in obtaining out all that you can about...

New York Marriage Licenses Online Lookup

With a large database for important public documents currently available from selected state agencies for the general publicAC/a!aC/s convenience, it's easier to obtain this essential and legally prepared information, nowadays. Nyc Marriage Records and ot...

Kentucky Separation Reports

The advancement in technology might be compared to the increase of cases of divorce, that is why it truly is understandable that almost all of western countries are legalizing divorce. It might be sad to see that a lot of married couples resorted to divor...

How To Proceed When You Need A Lawyer

If there are some pressing legal issues you are dealing with, you want good representation. It's not always easy to find the right attorney for your case, but it's the best bet. By using the advice in this article, you will be able to make better decision...

Keyword Selected: (Madras)

Insulin pill may delay type 1 diabetes in some

It’s often said that timing is everything. New research suggests this may be true when giving an insulin pill to try to prevent or delay type 1 diabetes. Researchers tested the effect of insulin pills on 560 children and adults whose relatives had type 1 diabetes. For most of them, the drug had no effect on whether or not they developed type 1 diabetes, or how quickly they developed it. But for those at the highest risk of developing type 1 diabetes sooner rather than later, insulin pill therapy delayed the time it took to develop the full-blown disease by about two-and-a-half years, the researchers said.

OneTouch Via enabled diabetes patients to report improved insulin dose compliance

People with type 1 and type 2 diabetes who used the new OneTouch Via™ mealtime, on-demand insulin delivery system reported they missed fewer doses and felt less stress about dosing compared to multiple daily injections, according to research presented by Calibra Medical, Inc., one of the Johnson & Johnson Diabetes Care Companies, at the annual American Diabetes Association (ADA) conference. Results of the Market Acceptance Evaluation (MAE) study also demonstrated that physicians were more likely to recommend the innovative insulin delivery device to patients who are not at A1C goals or who are new to rapid-acting insulin (RAI) therapy. The new OneTouch Via™ is a wearable, on-demand insulin delivery system in development that allows patients to discreetly deliver rapid-acting, or bolus, insulin at mealtimes by simply pressing two buttons on the device, accessible even through clothing. The thin, water-resistant patch can be worn continuously for up to three days, providing injection-free delivery of insulin when needed. “People with diabetes can often feel embarrassment or discomfort when they need to inject insulin at mealtimes or when snacking. In a social situation, they may choose to miss a dose so they don’t have to take themselves out of the moment, but avoiding needed insulin doses may lead to serious health complications over time,” said Dr. Brian Levy, Chief Medical Officer, Lifescan, Inc. “Because patients in the study were empowered to dose discreetly with the OneTouch Via™, they felt encouraged to dose more often - and ultimately, they reported missing fewer doses and better adherence to their treatment regimen.”

Rice study details stress-diabetes link

A Rice University study has found a link between emotional stress and diabetes, with roots in the brain’s ability to control anxiety. That control lies with the brain’s executive functions, processes that handle attention, inhibition, working memory and cognitive flexibility and are also involved in reasoning, problem-solving and planning. The study published in Psychoneuroendocrinology establishes a metabolic chain reaction that starts with low inhibition, aka attention control, which leaves a person vulnerable to tempting or distracting information, objects, thoughts or activities. Previous studies have shown that such vulnerability can lead to more frequent anxiety, and anxiety is known to activate a metabolic pathway responsible for the production of pro-inflammatory cytokines, signaling proteins that include interleukin-6 (IL-6).

Liraglutide may help nondiabetic overweight and obese adults lose weight and lower risks

For people with prediabetes who are overweight or obese, adding 3.0 mg of liraglutide for three years to a diet and exercise plan may lead to major health improvements, new industry-sponsored research suggests. The results will be presented Monday, April 4, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston. “Treatment with subcutaneous liraglutide 3.0 mg for three years, combined with a reduced-calorie diet and increased physical activity, can help people to not only lose weight, but also reduce the risk of Type 2 diabetes and improve cardiometabolic risk factors, which may ultimately reduce the risk of cardiovascular disease - the number one cause of death globally,” said lead study author Ken Fujioka, MD, director of nutrition and metabolic research, and director for weight management at Scripps Research Institute in La Jolla, California. “Type 2 diabetes is a major cause of death in the US. Both obesity, a chronic disease with serious health consequences, and prediabetes, typically defined as blood glucose concentrations that are higher than normal but lower than diabetes thresholds, increase the risk of developing Type 2 diabetes,” Fujioka said. “For people with overweight or obesity and prediabetes, losing between 5 and 10 percent of their body weight can reduce their risk of Type 2 diabetes and other obesity-related health consequences.”

Seaweed capsules may lead to an injection-free life for diabetic patients

Diabetes is one of the leading causes of death. Patients with type 1 diabetes have their insulin secreting cells destroyed by the immune system and require daily insulin injections. Pancreatic islet transplantation is an effective treatment that can dramatically reduce daily doses or even eliminate dependence on external insulin. Insulin producing cells are injected into a recipient liver. After an adaptation period they start to produce sufficient hormone needed by diabetic patients. However, while the transplantation procedure itself has been greatly improved in recent years, collection, preservation, and transportation of these cells are still very challenging. Research published in Advanced Healthcare Materials by the scientists from the Okinawa Institute of Technology and Science Graduate University (OIST) in collaboration with the University of Washington and Wuhan University of Technology offers a solution for some of these problems. Production and secretion of insulin occur in the pancreas - an endocrine gland in the digestive system. Cells secreting insulin are clustered in pancreatic islets. Despite their crucial role in organismal wellbeing these islets comprise only a few percent of the pancreatic tissue. The islet transplantation does not require major surgical intervention and is often done under local anaesthesia. It is also cheaper and might be safer than transplantation of the entire pancreas. Unfortunately, so far, only human islets can be transplanted and their supply is but a trickle.

Plant hormone may play a vital role in blood sugar control and diabetes management

A treatment for managing blood sugar levels might be as close as the local health food store, suggests a new research report published in the December 2015 issue of The FASEB Journal. Specifically scientists from Italy have found that when the plant and mammal hormone, abscisic acid, is taken in low doses, glycemia in both rats and humans is reduced. This suggests that by reducing the chronic stimulation by hyperglycemia of β-cells to the release of insulin, chronic low-dose abscisic acid administration may prolong the survival and function of these cells. “These results warrant further studies, aimed at developing new pharmacologic approaches to diabetes prevention and/or treatment,” said Mirko Magnone, Ph.D., a researcher involved in the work from the Department of Experimental Medicine at the University of Genova School of Medicine in Genova, Italy. Scientists examined the presence of abscisic acid in plants and fruits and explored the effect of abscisic acid-rich vegetable extracts on glycemia in rats and in humans. Synthetic abscisic acid, an abscisic acid-rich fruit extract, or placebo were administered to rats together with an oral glucose load. Then glycemia and insulinemia profiles were compared. Then a fruit extract or placebo was administered to human volunteers together with an oral glucose load or with a standard breakfast and lunch. Glucose and insulin levels were then compared with and without abscisic acid. Glycemia and insulinemia profiles from the human oral glucose tolerance tests were also compared with those from 12 normal subjects undergoing a standard oral glucose tolerance test.

Genetic variant shown to influence women’s body shape and diabetes risk

A genetic variant near the KLF14 gene regulates hundreds of genes that govern how and where women’s bodies store fat, which affects their risk of developing Type 2 diabetes, according to research presented at the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore. Specifically, different alleles, or versions, of the variant cause fat-storing cells to function differently. “At the whole-body level, these differences between alleles are not associated with changes to overall weight or body mass index, but they do affect women’s hip circumference,” explained Kerrin Small, PhD, Head of the Genomics of Regulatory Variation Research Group at King’s College London and lead author on the study. “Previous studies have shown that on average, women who carry fat in their hips - those with a ‘pear-shaped’ body type - are significantly less likely to develop diabetes than those with smaller hips. Looking at the variant we studied, large-scale genome-wide association studies show that women with one allele tend to have larger hips than women with the other one, which would have a protective effect against diabetes,” she said.

Endoplasmic reticulum stress plays significant role in type 2 diabetes

A new research report published in the October 2015 issue of the Journal of Leukocyte Biology, suggests that the endoplasmic reticulum plays a more important role in type 2 diabetes and its complications than previously believed. Specifically, when this cell compartment undergoes disruptions (stress) patients experienced poor glycemic control, dyslipidemia, insulin resistance and inflammatory and oxidative stress. Targeting ER stress might be an effective treatment strategy for type 2 diabetes. “In a way, we observed a ‘disharmonious stress signaling alliance’ in diabetes,” said Muthuswamy Balasubramanyam, a senior researcher and disease-biologist involved in the work from the Madras Diabetes Research Foundation in Chennai, India. “The future of potential practical applications of our research is that this would lead to the development of ‘chemical chaperones’ as a new generation class of anti-diabetic agents that should improve ER folding capacity, help to stabilize protein conformation and ameliorate ER stress,” he added. To make their discovery, scientists identified several endoplasmic reticulum stress markers increased in cells from patients with type 2 diabetes as compared to healthy control subjects.

Identifying the ‘dimmer switch’ of diabetes

Patrick MacDonald has dedicated much of his life to diabetes research. It’s a job he knows is far too large and complex for any one person, but with his latest publication, he knows his work is playing a part. MacDonald, a Canada Research Chair in Islet Biology, associate professor in the University of Alberta’s Faculty of Medicine & Dentistry and member of the Alberta Diabetes Institute, is the senior author of a landmark study in the Journal of Clinical Investigation. The researchers examined pancreatic islet cells from 99 human organ donors and identified a new molecular pathway that manages the amount of insulin produced by the pancreatic cells - essentially a ‘dimmer’ switch that adjusts how much or how little insulin is secreted when blood sugar increases. According to MacDonald, the dimmer appears to be lost in Type 2 diabetes but can be restored and ‘turned back on’ - reviving proper control of insulin secretion from islet cells of people with Type 2 diabetes.

Pot Smoking May Increase Prediabetes Risk

Marijuana use in early adulthood was associated with an increased risk for prediabetes, but not diabetes, by middle adulthood in an adjusted analysis of data from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Current marijuana use was associated with a 65% increase in prediabetes risk and very frequent use (≥100 uses) was associated with a 49% increase in risk, researcher Michael P. Bancks, MPH, of the University of Minnesota, in Minneapolis, and colleagues wrote in the journal Diabetologia. Previous Studies Suggest Metabolic Benefit The findings appear to contradict those of many previous studies, which suggest an overall beneficial effect on metabolic risk associated with marijuana use.

Keyword Selected: India

What Would Joe Stiglitz Do about WTO Subsidies Rules?

In a recent Foreign Policy piece, economist Joe Stiglitz makes several references to WTO rules "forbidding" industrial subsidies: The current moment is a good illustration. It is the product of longstanding beliefs and power relations. Under this system, industrial subsidies...

Katherine Tai on Negotiating at the WTO

Here's an exchange between Rep. Don Beyer (D-VA) and U.S. Trade Rep. Katherine Tai at a House Ways and Means Committee hearing in mid-April: Beyer: I, with a number of my colleagues here, visited the WTO a couple of years...

Is AD/CVD the Answer to Chinese Non-Market Policies and Practices?

In a recent Washington Post op-ed, Brian Deese, the former director of the National Economic Council in the Biden administration, calls for a coordinated use of AD/CVDs as a way to "discourage" China's "anti-market behavior": Responding to Chinaas anti-market behavior...

Overcapacity and future discussions in the SCM Committee.

Finbarr Bermingham reported on Wednesday, April 23, 2024, that in the recent SCM Committee meeting, there were asharpa exchanges between the US and China related to Chinese aovercapacitya in key sectors owing to subsidies. China objects to the term aovercapacity,a...

Developing country status in the WTO

Buried deep in the EU - Palm Oil report (paras. 7.911-7.915, on page 250!) is a nugget on developing country status in the WTO. Malaysia asserts, in the TBT context, that it is a developing Member. It cites as support...

Katherine Tai on WTO Complaints against China

U.S. Trade Rep. Katherine Tai had a couple exchanges at last week's Senate Finance Committee hearing in which she suggested that WTO complaints against China had not been effective, and for that reason the Biden administration had moved away from...

Katherine Tai on Trade Policy Pitting Americans against Americans

At a House Ways and Means Committee hearing last week, U.S. Trade Representative Katherine Tai said a couple times that she wanted "to stop pitting Americans against Americans" in U.S. trade policy: "Trade should work for all Americans. Our goal...

Senator Whitehouse and Ambassador Tai Talk About Getting Rid of ISDS

Here's an exchange between Senator Sheldon Whitehouse (D-RI) and U.S. Trade Rep. Katherine Tai at a Senate Finance Committee hearing today (2:32:00): Whitehouse: The other thing I wanted to talk with you about is the loathsome ISDS process. We are...

Subsidies, Overcapacity, and Domestic Demand/Savings

There has been a lot of discussion recently about how Chinese subsidies and other government support has led to industrial overcapacity, which can have a negative impact on the manufacturing sector of other economies. If domestic supply exceeds domestic demand,...

Free Trade and Peace Sells ... but Who's Buying?

I remain puzzled by some recent statements questioning whether free trade promotes peace. When I read another one in the Boston Review, I thought I was going to have to go through all my old rebuttals again. The article starts...

The Role of the WTO in Planetary Sustainability

The Role of the WTO in Planetary Sustainability Steve Charnovitz 6 April 2024 Promoting planetary sustainability is within the legal competence of all multilateral organizations. As a result, no international organization is likely to have an exclusive competence to effectuate...

USTR's New Vision for Foreign Trade Barriers

Last week, in the press release for its 2024 National Trade Estimate Report on Foreign Trade Barriers, USTR said that over the years, the identification of trade barriers in this annual report has strayed from the original purpose of the...

Digital Trade Fights: The Case of Korea

In recent years, the U.S. has expressed concerns about digital trade regulation in a number of other countries, with the focus tending to be on the the EU due to its large market and active regulatory efforts (although it sounds...

Data Flows Obligations and Exceptions in the EU - New Zealand FTA

There's a new FTA digital chapter to analyze, with the EU-New Zealand FTA coming into force soon. Let's take a look at the data flows provisions, with the EU-Japan text in the back of our minds as a comparison. The...

New U.S. AD/CVD Regulations Will Take Into Account Weak Property, IP, Human Rights, Labor, Environmental Protections

In a Proposed Rule issued last year, the U.S. Commerce Department said it would take into account "nonexistent, weak, or ineffective property (including intellectual property), human rights, labor, and environmental protections" in various ways as part of its anti-dumping/countervailing duty...

Guest Post: EFTA-India TEPA: Breaking New Ground

This is a guest post by Rohan, a PhD student at the Graduate Institute India and the EFTA countries (Iceland, Liechtenstein, Norway, and Switzerland) signed a comprehensive Trade and Economic Partnership Agreement (TEPA) on 10th March, 2024 after a long...

Is Section 301 the Right Remedy for Chinese Shipbuilding Subsidies?

In the Section 301 petition recently filed by a group of unions, the petitioners argued that "Section 301 provides an appropriate mechanism for addressing Chinaas policies in the maritime, logistics, and shipbuilding sector." They offer three reasons for this: First,...

Katherine Tai on Online Business Models and Digital Regulation

U.S. Trade Rep. Katherine Tai spoke recently at a SeedAI event and had some interesting things to say about both online business models and digital trade regulation. I'll start with a quote that reflects what she has said many times...

Did NAFTA Push White Male Social Conservatives to the Republican Party?

This is the abstract of a new paper titled "Local Economic and Political Effects of Trade Deals: Evidence from NAFTA", which argues that many "white, less educated voters left the Democratic Party" due to NAFTA: Why have white, less-educated voters...

Guest Post: Back from the WTO MC13 a A brief report and some remarks from four scholars who were in Abu Dhabi

This is a guest post by several people from the Research Chair on New Challenges of Economic Globalization, Laval University, Quebec City, Canada: Carla Gomez, Ph.D. Researcher; Antoine Comont, Ph.D. Researcher; Van Anh Ly, Ph.D., Deputy Director of the Research...

Let Them Eat Cake? Reflections on the Labor Provisions in the New India-EFTA Agreement

Iave never understood the expression: they want to have their cake and eat it too. Who on this planet wants to hold onto a piece of cake and not eat it?!? I was at a birthday party this weekend, and...

Mexico Invokes Public Morals, Exhaustible Natural Resources, Indigenous Peoples Exceptions in GE Corn USMCA Dispute

Mexico's initial written submission in the GE Corn USMCA dispute was recently posted. The English public version is here. There's a lot in there and I'm not going to go through it all in this post. I just thought it...

Resolving the Biden Administration's Internal Debate on International Digital Rules, and Reengaging in Negotiations

I've already made these points for the trade policy crowd, but I have now tried to make my pitch on a way forward for the Biden administration on international digital trade rules slightly more accessible (i.e., without so many blockquotes...

Katherine Tai on USMCA Dispute Settlement and the USMCA Six Year Review

At a Brookings event yesterday, Josh Meltzer of Brookings had some interesting exchanges with U.S. Trade Rep. Katherine Tai on USMCA dispute settlement and the USMCA six year review. Here's the one on dispute settlement: Meltzer: What I'd like to...

Conversations at WTO Ministerial Side Events: Subsidy Races and Trade Remedies

As part of the WTO Ministerial Conference last week, there were some side events going on. I was watching one called "Business Forum at MC13" and came across some interesting discussion of subsidy races and trade remedies. The question that...

The Role of WTO Case Law in a USMCA RRLM Proceeding

Here is an interesting exchange from last week's hearing in the USMCA San MartAn mine labor dispute about the role of WTO case law in interpreting the USMCA provisions at issue: Panelist: Mexico raised the question that the United States...

WTO Adverse Effects Complaints vs. Domestic CVD Cases

Subsidies have been in the news a lot recently, as China's subsidies continue to cause concerns, and the Biden administration and others are now increasing their own use of subsidies. In trade policy, the reaction to foreign subsidies tends to...

Page took 3 seconds to load.

News on DHAKA, Bangladesh

Century Park Law Group is Los Angeles Car Accident Lawyer

Home Page